Proneuron, Teva Pharmaceuticals Industries Inc. deal

TEVA and Proneuron partnered to develop glatiramer to treat multiple acute and chronic neurological diseases. TEVA will fund preclinical and clinical development and will pay Proneuron milestones and ...